ClinicalTrials.govpublic full text
Treatment of Refractory cGVHD by Donor-derived Treg Cell Injection Combined With Recombinant Human Interleukin-2
cgvhd, steroid dependence, refractory cgvhd, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 862461
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.